Telesis Bio Inc (TBIO)

0.3152 +0.0062 (+2.01%)
Closed USD Disclaimer
0.3300 +0.0148 (+4.6954%)

Telesis Bio Inc Company Profile

Sector
Healthcare
Employees
142
Equity Type
ORD
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Contact Information
Address
San Diego,92121-2993 United States
Phone
858 228 4115
Fax
-
Top Executives
Name
Age
Since
Title
Franklin R. Witney 69 2020 Independent Chair of the Board
Andrea L. Jackson 45 2021 Independent Director
Todd R. Nelson 57 2018 Founder & Director
Stephen Schoenberger 0 0000 Member of Strategic Advisory Board
Aaron Miller 0 0000 Member of Strategic Advisory Board
Jami K. Dover Nachtsheim 65 2021 Independent Director
Christine A. Tsingos 65 2021 Independent Director
Annette V. Tumolo 69 2022 Independent Director
Paul M. Meister 71 2023 Director
Eric Esser 55 2022 President, CEO, COO & Director
Gregory J. Herrema 58 0000 Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.